IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q4 2015 Holdings

Filed 2016-02-16 | 14 holdings | $1.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ophthotech CorpCOM683745103$385.6K4,910,48737.1%
Vanguard Index FDS(VTI)TOTAL STK MKT922908769$310.7K2,979,10029.9%
Inogen Inc(INGN)COM45780L104$142.3K3,549,32013.7%
Vanguard Intl Equity Index F(VGK)FTSE EUROPE ETF922042874$104.8K2,101,00010.1%
Colucid Pharmaceuticals IncCOM19716T101$25.6K3,056,5632.5%
Tobira Therapeutics IncCOM88883P101$24.8K2,471,4052.4%
Penumbra, Inc.(PEN)COM70975L107$12.7K236,1441.2%
Nabriva Therapeutics AGCOM62957M104$8.4K874,9850.8%
Invuity IncCOM46187J205$8.2K925,0000.8%
HTG Molecular Diagnostics IncCOM40434H104$5.6K1,280,1850.5%
Wright Medical GroupCONTINGENT VALUE RIGHTS98235T115$4.7K$4,622,0320.5%
Tokai Pharmaceuticals IncCOM88907J107$4.1K470,9460.4%
Glaukos Corp(GKOS)COM377322102$1.9K75,0000.2%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$1.0K127,5630.1%